Aerovance, Inc.
2929 Seventh Street
Suite 120
Berkeley
California
94710
United States
Tel: 510-549-5500
Fax: 510-549-5501
Website: http://www.aerovance.com/
Email: info@aerovance.com
13 articles about Aerovance, Inc.
-
Phase 2b Clinical Trial Results Show Aerovance, Inc.'s Aerovant(TM) is Effective in Patients with Eosinophilic Asthma
6/8/2010
-
Aerovance, Inc. Secures $38 Million in Equity Financing
4/7/2009
-
Aerovance, Inc. Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
3/2/2009
-
Aerovance, Inc. Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
2/9/2009
-
Data Show Aerovance, Inc.'s Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
10/7/2008
-
Aerovance, Inc. Secures $20 Million in Debt Financing
3/28/2008
-
Aerovance, Inc. Promotes Anthony Rimac to Vice President, Chief Financial Officer
10/30/2007
-
Aerovance, Inc. Names Mark L. Perry President And CEO
1/4/2007
-
Aerovance, Inc. Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
1/3/2007
-
Aerovance, Inc. Adds Accomplished Product Commercialization Executive To Leadership Team
12/18/2006
-
Aerovance, Inc. Announces Key Board Appointments
11/16/2006
-
Aerovance, Inc. Secures $60 Million In Series C Financing
5/5/2006
-
Aerovance, Inc. Appoints William J. Newell As President
2/8/2006